Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors

Systemic and intrathecal administration of derivatives of a nonpsychoactive component of marijuana significantly suppresses chronic inflammatory and neuropathic pain, without causing analgesic tolerance, in several rodent models.

• Publication year

  2012

• Venue

  Journal of Experimental Medicine

• Publication date

  2012-06-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1084/jem.20120242PMID 22585736PMCID 3371734
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Common Molecular Basis for Exogenous and Endogenous Cannabinoid Potentiation of Glycine Receptors

  2012cited by this paper
• Chronic pain states: pharmacological strategies to restore diminished inhibitory spinal pain control.

  2012influential reference
• Analgesia: Inhibiting neuropathic pain

  2011cited by this paper
• Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials.

  2011cited by this paper
• Allosteric modulation of glycine receptors

  2011cited by this paper
• Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia.

  2011influential reference
• Molecular Sites for the Positive Allosteric Modulation of Glycine Receptors by Endocannabinoids

  2011cited by this paper
• Serotonin receptor 1A-modulated phosphorylation of glycine receptor α3 controls breathing in mice.

  2010cited by this paper
• Cannabinoid CB1 receptor facilitation of substance P release in the rat spinal cord, measured as neurokinin 1 receptor internalization

  2010cited by this paper
• Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia

  2010cited by this paper
• Lack of positive allosteric modulation of mutated α1S267I glycine receptors by cannabinoids

  2010cited by this paper
• Examining the roles of cannabinoids in pain and other therapeutic indications: a review

  2010cited by this paper
• A Selective Role for α3 Subunit Glycine Receptors in Inflammatory Pain

  2009influential reference
• Modulation of Glycine Receptor Function by the Synthetic Cannabinoid HU210

  2009cited by this paper
• Positive allosteric modulatory effects of ajulemic acid at strychnine-sensitive glycine α1- and α1β-receptors

  2009cited by this paper
• Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury

  2009cited by this paper
• The Nonpsychotropic Cannabinoid Cannabidiol Modulates and Directly Activates Alpha-1 and Alpha-1-Beta Glycine Receptor Function

  2009cited by this paper
• Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.

  2009cited by this paper
• Spinal Endocannabinoids and CB1 Receptors Mediate C-Fiber–Induced Heterosynaptic Pain Sensitization

  2009cited by this paper
• CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fields

  2009cited by this paper
• Transient receptor potential channels: targeting pain at the source

  2009cited by this paper
• CHARMM: The biomolecular simulation program

  2009cited by this paper
• Animal models of pain: progress and challenges

  2009cited by this paper
• Residual dipolar coupling measurements of transmembrane proteins using aligned low-q bicelles and high-resolution magic angle spinning NMR spectroscopy.

  2008cited by this paper
• Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine.

  2008cited by this paper
• Anandamide Inhibition of 5-HT3A Receptors Varies with Receptor Density and Desensitization

  2008cited by this paper
• Peripherally acting mu‐opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury

  2008cited by this paper
• Increased C-Fiber Nociceptive Input Potentiates Inhibitory Glycinergic Transmission in the Spinal Dorsal Horn

  2008cited by this paper
• Molecular dynamics simulations of ternary membrane mixture: phosphatidylcholine, phosphatidic acid, and cholesterol.

  2007cited by this paper
• Neuronal mechanism for neuropathic pain

  2007influential reference
• Cannabis, the mind and society: the hash realities

  2007cited by this paper
• The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain.

  2007cited by this paper
• Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double‐blind, placebo‐controlled clinical trial

  2007cited by this paper
• On the pharmacological properties of Delta9-tetrahydrocannabinol (THC).

  2007cited by this paper
• On the Pharmacological Properties of Δ9‐Tetrahydrocannabinol (THC)

  2007cited by this paper
• Comparative Protein Structure Modeling Using MODELLER

  2007cited by this paper
• Glycine receptors: a new therapeutic target in pain pathways.

  2006cited by this paper
• Spinal prostaglandin E receptors of the EP2 subtype and the glycine receptor &agr;3 subunit, which mediate central inflammatory hyperalgesia, do not contribute to pain after peripheral nerve injury or formalin injection

  2006cited by this paper
• Δ9-Tetrahydrocannabinol and Endogenous Cannabinoid Anandamide Directly Potentiate the Function of Glycine Receptors

  2006cited by this paper
• Cannabinoid Analgesia as a Potential New Therapeutic Option in the Treatment of Chronic Pain

  2006cited by this paper
• Role of the Immune system in chronic pain

  2005cited by this paper
• Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol.

  2005cited by this paper
• Structure and dynamics of the second and third transmembrane domains of human glycine receptor.

  2005influential reference
• The glycinergic control of spinal pain processing

  2005cited by this paper
• Scalable molecular dynamics with NAMD

  2005cited by this paper
• GlyR α3: An Essential Target for Spinal PGE2-Mediated Inflammatory Pain Sensitization

  2004influential reference
• Molecular structure and function of the glycine receptor chloride channel.

  2004cited by this paper
• Optimization of Structures and LJ Parameters of 1-Chloro-1,2,2-trifluorocyclobutane and 1,2-Dichlorohexafluorocyclobutane

  2004cited by this paper
• Primary afferent stimulation differentially potentiates excitatory and inhibitory inputs to spinal lamina II outer and inner neurons.

  2004cited by this paper
• Parametrization of 2-Bromo-2-Chloro-1,1,1-Trifluoroethane (Halothane) and Hexafluoroethane for Nonbonded Interactions

  2004cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• The Significance of Intrathecal Catheter Location in Rats

  2003cited by this paper
• The significance of intrathecal catheter location in rats.

  2003cited by this paper
• PGE(2) selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons.

  2002cited by this paper
• PGE2 selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons

  2002cited by this paper
• International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

  2002cited by this paper
• Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord.

  2001cited by this paper
• Prostaglandins and cycloxygenases in the spinal cord

  2001cited by this paper
• Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor.

  2000cited by this paper
• Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.

  1999cited by this paper
• Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

  1998influential reference
• NMRPipe: A multidimensional spectral processing system based on UNIX pipes

  1995cited by this paper
• Quantitative assessment of tactile allodynia in the rat paw.

  1994cited by this paper
• A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

  1987cited by this paper
• Afferent and efferent connections of the rat tail flick reflex (a model used to analyze pain control mechanisms)

  1982cited by this paper
• Intrathecal morphine in mice: a new technique.

  1980cited by this paper
• Efficient analysis of experimental observations.

  1980cited by this paper
• Note on an Approximation Treatment for Many-Electron Systems

  1934cited by this paper

• Utilizing Machine Learning for Raman Spectral Data Analysis of Brain Tissue

  2026cites this paper
• CB1R and GlyT2 interaction in spinal glycinergic circuits drives neuropathic mechanical pain.

  2026cites this paper
• Investigating Cannabidiol's Effectiveness to Mitigate the Adverse Consequences of Exposure to Neonatal Procedural Pain.

  2026cites this paper
• Rapid suppression of neuropathic pain and somatosensory hyperactivity by nano-formulated cannabidiol.

  2025cites this paper
• Molecular targets of cannabinoids and their derivatives in epilepsy – a review with focus on CBD

  2025cites this paper
• Cannabidiol reduces oxycodone self-administration while preserving its analgesic efficacy in a rat model of neuropathic pain

  2025cites this paper
• Spinal dorsal horn neurons involved in the alleviating effects of cannabinoid receptor agonists on neuropathic allodynia-like behaviors in rats.

  2025cites this paper
• The cannabinoid CB2 receptor mediates the analgesic effects of Cannabis sativa extract in a rat model of neuropathic pain.

  2025cites this paper
• A Randomized, Open-Label Trial to Assess Feasibility and Tolerability of Topical Cannabis Balms for the Treatment of Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS)

  2025cites this paper
• Early oral administration of THC:CBD formulations prevent pain-related behaviors without exacerbating paclitaxel-induced changes in weight, locomotion, and anxiety in a rat model of chemotherapy-induced neuropathy

  2025cites this paper
• Cannabis sativa Root Extract Exerts Anti-Nociceptive and Anti-Inflammatory Effects via Endocannabinoid Pathway Modulation In Vivo and In Vitro

  2025cites this paper
• Psychoactive substances: novel molecular insights and therapeutic potential for Alzheimer's disease

  2025cites this paper
• The Development and Therapeutic Potential of Classical and Next-Generation Cannabinoid Ligands.

  2025cites this paper
• Grifolic acid, a FFAR4 agonist, identified as a dual antagonist of voltage‐gated sodium and CaV2.2 channels with potent antinociceptive effects

  2025cites this paper
• Neurexin regulates mechanical nociceptive sensitization by central inhibition in Drosophila

  2025cites this paper
• Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy

  2025cites this paper
• Cannabidiol from Conventional to Advanced Nanomedicines for the Management of Cancer-Associated Pain.

  2025cites this paper
• Cannabidiol reduces neuropathic pain and cognitive impairments through activation of spinal PPARγ.

  2025cites this paper
• Structure and Dynamics of Cannabinoid Binding to the GABAA Receptor

  2025cites this paper
• Cannabidiol - a friend or a foe?

  2025cites this paper
• Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT2A receptor.

  2025cites this paper
• Fluorescence-based method for analysis of glycine receptor alpha 3 agonists.

  2025cites this paper
• Combating Drug Abuse among Students in Nigerian Tertiary Institutions: Prevention and Management Strategies

  2025cites this paper
• Innovative Strategies to Enhance the Bioavailability of Cannabidiol: Nanotechnology and Advanced Delivery Systems

  2025cites this paper
• Topical Cannabidiol for Established Chemotherapy-Induced Neuropathy: A Pilot Randomized Placebo-Controlled Trial

  2024cites this paper
• Unraveling the Mechanisms of Cannabidiol’s Pharmacological Actions: A Comprehensive Research Overview

  2024cites this paper
• The Development of Cannabinoids as Therapeutic Agents in the United States

  2024cites this paper
• Analgesic Properties of Next-Generation Modulators of Endocannabinoid Signaling: Leveraging Modern Tools for the Development of Novel Therapeutics

  2024cites this paper
• Biodegradable cannabidiol: a potential nanotherapeutic for neuropathic pain

  2024cites this paper
• Cannabidiol and pain.

  2024cites this paper
• New insights into the involvement of serotonin and BDNF-TrkB signalling in cannabidiol's antidepressant effect.

  2024cites this paper
• Cannabidiol and its application in the treatment of oral diseases: therapeutic potentials, routes of administration and prospects.

  2024cites this paper
• Cannabinoids for Acute Pain Management: Approaches and Rationale

  2024cites this paper
• Effects of acute cannabidiol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice

  2024cites this paper
• Perioperative Analgesic and Sedative Effects of Cannabidiol in Cats Undergoing Ovariohysterectomy

  2024cites this paper
• Exploring the Possible Role of Cannabinoids in Managing Post-cardiac Surgery Complications: A Narrative Review of Preclinical Evidence and a Call for Future Research Directions

  2024cites this paper
• Exploring the therapeutic potential of cannabidiol for sleep deprivation-induced hyperalgesia.

  2024cites this paper
• Inverse electron demand Diels-Alder reaction in total synthesis of bioactive natural products

  2024cites this paper
• Cannabidiol ameliorates cognitive decline in 5×FAD mouse model of Alzheimer’s disease through potentiating the function of extrasynaptic glycine receptors

  2024cites this paper
• Structural Basis for Molecular Recognition of Cannabinoids by Inhibitory Cys-Loop Channels.

  2024cites this paper
• Modulation of heteromeric glycine receptor function through high concentration clustering

  2024cites this paper
• Mechanisms underlying modulation of human GlyRα3 by Zn2+ and pH

  2024cites this paper
• Deformable Vesicles with Edge Activators for the Transdermal Delivery of Non-Psychoactive Cannabinoids.

  2024cites this paper
• The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders

  2024cites this paper
• Topical use of cannabis oil for wound healing in a dog

  2024cites this paper
• Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders

  2024cites this paper
• Minor Cannabinoids as an Emerging Frontier for Pain Relief

  2024cites this paper
• Genotype-specific morphophysiological adaptations and proline accumulation uncover drought adaptation complexity in hemp (Cannabis sativa and Cannabis indica)

  2024cites this paper
• Prevalence and risk factors of Preterm Births in Northern Uganda: A Hospital-Based Study at Lira Regional Referral Hospital

  2024cites this paper
• A millisecond coarse-grained simulation approach to decipher allosteric cannabinoid binding at the glycine receptor α1

  2024cites this paper
• Cannabis-Based Phytocannabinoids: Overview, Mechanism of Action, Therapeutic Application, Production, and Affecting Environmental Factors

  2024cites this paper
• Schisandrin B from Schisandra chinensis alleviated pain via glycine receptors, Nav1.7 channels and Cav2.2 channels.

  2024cites this paper
• Therapeutic potential of cannabidiol in depression.

  2024cites this paper
• Phytocannabinoids in neuromodulation: from omics to epigenetics.

  2024cites this paper
• Cannabis for medicinal use in patients with rare diseases

  2023cites this paper
• Research Progress on the Role of Cannabidiol in Neuropathic Pain

  2023cites this paper
• Cannabidiol Treatment Shows Therapeutic Efficacy in a Rodent Model of Social Transfer of Pain in Pair-Housed Male Mice

  2023cites this paper
• Glycine: The Smallest Anti-Inflammatory Micronutrient

  2023cites this paper
• The cannabinoid dehydroxylcannabidiol suppresses neuropathic pain by upregulating a spinal glycine receptor-mediated compensation mechanism

  2023cites this paper
• The Polypharmacological Effects of Cannabidiol

  2023cites this paper
• IUPHAR review- Preclinical models of neuropathic pain: Evaluating multifunctional properties of natural cannabinoid receptors ligands

  2023cites this paper
• AAV-glycine receptor α3 alleviates CFA-induced inflammatory pain by downregulating ERK phosphorylation and proinflammatory cytokine expression in SD rats

  2023cites this paper
• Assessing Dose- and Sex-Dependent Antinociceptive Effects of Cannabidiol and Amitriptyline, Alone and in Combination, and Exploring Mechanism of Action Involving Serotonin 1A Receptors

  2023cites this paper
• Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration

  2023cites this paper
• Evaluation of cannabidiol nanoparticles and nanoemulsion biodistribution in the central nervous system after intrathecal administration for the treatment of pain.

  2023cites this paper
• Cannabidiol represses miR-143 to promote cardiomyocyte proliferation and heart regeneration after myocardial infarction.

  2023cites this paper
• An Overview of Cannabidiol.

  2023cites this paper
• supplementa-Cannabinoid oil with gabapentin for the treatment of chronic neuropathic pain – a case report

  2023cites this paper
• Distinct antinociceptive and conditioned behavioral effects are produced by individual cannabinoids and a cannabis-derived mixture.

  2023cites this paper
• Pharmacokinetics of Orally Applied Cannabinoids and Medical Marijuana Extracts in Mouse Nervous Tissue and Plasma: Relevance for Pain Treatment

  2023cites this paper
• Imaging and Genetic Tools for the Investigation of the Endocannabinoid System in the CNS

  2023cites this paper
• Cannabidiol prevents chemotherapy-induced neuropathic pain by modulating spinal TLR4 via endocannabinoid system activation.

  2023cites this paper
• Cannabidiol for the Treatment of Pediatric Epilepsy.

  2023cites this paper
• CBD as a cure‐all? The impacts of state‐level legalization of prescription cannabidiol (CBD) on opioid prescriptions

  2023cites this paper
• Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence

  2023influential citation
• Placebo-Controlled Trial of Daily Oral Cannabidiol as Adjunctive Treatment for Cats with Chronic Gingivostomatitis

  2023cites this paper
• A type II cannabis extract and a 1:1 blend of Δ(9)-tetrahydrocannabinol and cannabidiol display distinct antinociceptive profiles and engage different endocannabinoid targets when administered into the subarachnoid space

  2023cites this paper
• Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn’t

  2023cites this paper
• Cannabis sativa: A look at protozoa, helminths, insect vectors, and pests.

  2023cites this paper
• Neuropharmacology of endogenous, synthetic and phytocannabinoids for pain management

  2023cites this paper
• Cannabidiol and Cannabigerol, Nonpsychotropic Cannabinoids, as Analgesics that Effectively Manage Bone Fracture Pain and Promote Healing in Mice

  2023cites this paper
• Antinociceptive effect of gelsenicine, principal toxic alkaloids of gelsemium, on prostaglandin E2-induced hyperalgesia in mice: Comparison with gelsemine and koumine.

  2023cites this paper
• Streptozotocin-Induced Diabetic Rats Showed a Differential Glycine Receptor Expression in the Spinal Cord: A GlyR Role in Diabetic Neuropathy

  2023cites this paper
• Overview of the Endocannabinoid System and Endocannabinoidome

  2022cites this paper
• Inhibition of human recombinant T‐type calcium channels by phytocannabinoids in vitro

  2022cites this paper
• Anti-inflammatory potential of cannabidiol (CBD) on combination of caecal slurry, LPS, and E. coli-induced systemic inflammatory response syndrome (SIRS) in Sprague Dawley Rats

  2022cites this paper
• Direct Regulation of Hyperpolarization-Activated Cyclic-Nucleotide Gated (HCN1) Channels by Cannabinoids

  2022cites this paper
• Effects of cannabinoids on ligand-gated ion channels

  2022influential citation
• Molecular determinants of tetrahydrocannabinol binding to the glycine receptor

  2022cites this paper
• A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021

  2022cites this paper
• Cys-loop receptors on cannabinoids: All high?

  2022influential citation
• Ten reasons to consider cannabinoids in everyday clinical practice

  2022cites this paper
• Positive Allosteric Modulators of Glycine Receptors and Their Potential Use in Pain Therapies

  2022cites this paper
• Combined alcohol and cannabinoid exposure leads to synergistic toxicity by affecting cerebellar Purkinje cells

  2022cites this paper
• Spinal glycinergic currents are reduced in a rat model of neuropathic pain following partial nerve ligation but not chronic constriction injury.

  2022cites this paper
• Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model

  2022cites this paper
• Gelsemine relieves the neuropathic pain by down-regulating DPP4 in rats.

  2022cites this paper
• Structural basis for cannabinoid-induced potentiation of alpha1-glycine receptors in lipid nanodiscs

  2022cites this paper
• Role of glycine and glycine receptors in vascular endothelium: a new perspective for the management of the post-ischemic injury.

  2022cites this paper
• Evidence For Cannabidiol Modulation of Serotonergic Transmission in a Model of Osteoarthritis via in vivo PET Imaging and Behavioral Assessment

  2022cites this paper